Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-12-152108
Filing Date
2012-04-05
Accepted
2012-04-05 16:37:48
Documents
3
Effectiveness Date
2012-04-05

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d330443ddefa14a.htm DEFA14A 22091
2 GRAPHIC g330443g01a94.jpg GRAPHIC 185268
3 GRAPHIC g330443g01t47.jpg GRAPHIC 154598
  Complete submission text file 0001193125-12-152108.txt   491849
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-22873 | Film No.: 12746113
SIC: 2835 In Vitro & In Vivo Diagnostic Substances